백혈구 제거 기기 시장 : 장비 유형별, 용도별, 최종사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)

The global leukapheresis devices market is estimated to be valued at US$ 29.9 Million in 2023 and is expected to exhibit a CAGR of 7.9% during the forecast period (2023-2030).

Leukaemia is a medical procedure that involves separating white blood cells from a sample of blood. The procedure is undergone to reduce the quantity of white blood cells in patients wuth hematological malignancies. Therefore, leukapheresis devices are the medical devices that are used to facilitate this procedure. The surge in demand for leukopaks in clinical research is one of the major factors fostering the growth of the market. Growth in the number of activities associated with blood donations coupled with growing innovations and advancements in technologies is another market growth determinant. Rising health awareness among individuals, growing approvals for processes of isolating white blood cells (WBC), and rising medical tourism are other important factors that will further generate lucrative market growth opportunities.

Market Dynamics

This global leukapheresis devices market report provides details of recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. For instance, In December 2021, ExThera Medical develops revolutionary medical devices that address unmet clinical needs in the treatment of bloodstream infections and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, entered into an exclusive distribution agreement in Japan for ExThera's Seraph 100 Microbind Affinity Blood Filter (Seraph 100). As per the agreement structure, ExThera Medical and Asahi Kasei Medical will collaborate to obtain regulatory approval for Seraph 100 for commercialization in Japan. The global leukapheresis devices market is expected to witness significant growth during the forecast period, owing to the increasing prevalence of leukemia. For instance, in June 2022, Terumo Blood is in blood component, therapeutic apheresis and cellular technologies and Cell Technologies, a medical technology company specializing in a portfolio of products, software, and services for blood component collection, therapeutic apheresis, and cellular technologies, announced it had signed a new collaborative agreement with GenCure, a subsidiary of BioBridge Global, to extend and unify cell and gene therapy manufacturing solutions.

Key features of the study:

• This report provides an in-depth analysis of the global leukapheresis devices market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global leukapheresis devices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, BioIVT, Grifols, S.A, HemaCare, B. Braun Melsungen AG, Caltag Medsystems Limited, AllCells, StemExpress, PPA, Cellero, Precision for Medicine, Inc., The Intelligent Tissue Group Lonza, BioIVT, Lmb Technologie GmbH, Kaneka Medical Europe N.V. and Key Biologics, LLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding its future product launches, type up-gradation, market expansion, and marketing tactic
• The global leukapheresis devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukapheresis devices market

Detailed Segmentation:

• Global Leukapheresis Devices Market, By Device Type:
  • Apheresis Devices
  • Leukapheresis Columns & Cell Separators
  • Leukoreduction Filters
  • Leukapheresis Disposables
• Global Leukapheresis Devices Market, By Application :
  • Research Applications
  • Therapeutic Applications
• Global Leukapheresis Devices Market, By End User:
  • Hospitals
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Blood Component Providers
  • Blood Centers
• Global Leukapheresis Devices Market , By Region:
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Asahi Kasei Medical Co. Ltd.
  • Haemonetics Corporation
  • Terumo BCT Inc.
  • STEMCELL Technologies Inc.
  • Fresenius SE & Co. KGaA
  • BioIVT, Grifols, S.A
  • HemaCare
  • B.Braun Melsungen AG
  • Caltag Medsystems Limited
  • AllCells
  • StemExpress
  • PPA
  • Cellero
  • Precision for Medicine, Inc.
  • The Intelligent Tissue Group Lonza
  • BioIVT
  • Lmb Technologie GmbH
  • Kaneka Medical Europe N.V.
  • Key Biologics, LLC.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Device Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaboration
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Leukapheresis Devices Market- COVID-19 Impact Analysis

• Economic Impact
• COVID-19 Epidemiology
• Impact on Supply and Demand

5. Global Leukapheresis Devices Market, By Device Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Apheresis Devices
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Leukapheresis Columns & Cell Separators
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Leukoreduction Filters
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Leukapheresis Disposables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

6. Global Leukapheresis Devices Market, By Application, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Research Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Therapeutic Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Global Leukapheresis Devices Market, By End User, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Academic & Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Pharmaceutical & Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Blood Component Providers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
• Blood Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

8. Global Leukapheresis Devices Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018-2030
• North America
  • Introduction
  • Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Country, 2018-2030, (US$ Mn)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Device Type, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Application, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By End User, 2018-2030, (US$ Mn)
  • Market Size and Forecast, By Country/Region, 2018-2030, (US$ Mn)
• North Africa
• Central Africa
• South Africa
• Rest of Africa

9. Company Profiles

• Asahi Kasei Medical Co. Ltd.*
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Haemonetics Corporation
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Terumo BCT Inc.
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• STEMCELL Technologies Inc.
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Fresenius SE & Co. KGaA
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• BioIVT
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Grifols, S.A
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• HemaCare
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Braun Melsungen AG
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Caltag Medsystems Limited
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AllCells
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• StemExpress
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• PPA
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cellero
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Precision for Medicine, Inc.
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• The Intelligent Tissue Group Lonza
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Lmb Technologie GmbH
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Kaneka Medical Europe N.V.
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Key Biologics, LLC.
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies

10. Section

• Analyst view
• References
• Research Methodology

About us and Sales Contact*Browse 36 market data tables and 33 figures on "Leukapheresis Devices Market "- Global Forecast to 2030